Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals ; volume:23 ; number:1 ; day:25 ; month:5 ; year:2023 ; pages:1-8 ; date:12.2023
BMC gastroenterology ; 23, Heft 1 (25.5.2023), 1-8, 12.2023
- Creator
-
Tajiri, Kazuto
Okada, Kazuhiko
Ito, Hiroyuki
Kawai, Kengo
Kashii, Yoshiro
Tokimitsu, Yoshiharu
Muraishi, Nozomu
Murayama, Aiko
Hayashi, Yuka
Minemura, Masami
Takahara, Terumi
Shimizu, Yukihiro
Yasuda, Ichiro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-023-02829-w
- URN
-
urn:nbn:de:101:1-2023091013311961607300
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tajiri, Kazuto
- Okada, Kazuhiko
- Ito, Hiroyuki
- Kawai, Kengo
- Kashii, Yoshiro
- Tokimitsu, Yoshiharu
- Muraishi, Nozomu
- Murayama, Aiko
- Hayashi, Yuka
- Minemura, Masami
- Takahara, Terumi
- Shimizu, Yukihiro
- Yasuda, Ichiro
- SpringerLink (Online service)
Other Objects (12)
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Direct-acting antivirals and visceral leishmaniasis: a case report
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Direct-acting antivirals and visceral leishmaniasis: a case report
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Direct-acting antivirals and visceral leishmaniasis: a case report
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals